NovoCure NVCR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Geography | ||||||
| France | $81.21M+6.6% | $76.19M+6.4% | $71.63M+6.5% | $67.25M+6.6% | $63.1M+13.2% | |
| Germany | $85.19M+7.3% | $79.41M+5.2% | $75.51M+4.6% | $72.21M+5.8% | $68.23M+4.6% | |
| Greater China | $19.62M+0.9% | $19.44M+15.8% | $16.78M+6.2% | $15.81M-7.4% | $17.07M-1.8% | |
| Japan | $39.32M+4.1% | $37.79M+4.7% | $36.09M+2.3% | $35.28M+5.4% | $33.46M+2.7% | |
| Other international markets | $60.64M+6.6% | $56.9M+11.5% | $51.04M+9.4% | $46.65M+2.7% | $45.44M+7.0% | |
| United States | $388.43M+0.7% | $385.63M-1.4% | $391.23M-0.4% | $392.96M-0.4% | $394.41M+0.7% | |
| Total long lived assets by Geography | ||||||
| Israel | $126.87M-1.5% | $128.86M-1.6% | $130.92M+46.3% | $89.49M+85.0% | $48.38M+17.1% | |
| Switzerland | $123.97M-3.1% | $127.92M+19.8% | $106.81M-2.5% | $109.52M+1.2% | $108.21M+57.6% | |
| United States | $263.18M+0.8% | $261.1M+1.1% | $258.33M+4.9% | $246.27M+6.7% | $230.81M+8.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does NovoCure break its business down?
- NovoCure (NVCR) reports net revenues by geography across 6 parts — France, Germany, Greater China, Japan and Other international markets. Each is extracted from the segment footnotes and tracked over time.
- Where does NovoCure's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in NovoCure's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
